Deciphering ShcA-mediated ROS Production as a Novel Intervention Strategy in Diabetes Therapy
解读 ShcA 介导的 ROS 产生作为糖尿病治疗的新型干预策略
基本信息
- 批准号:9753262
- 负责人:
- 金额:$ 28.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinApoptosisApoptoticBindingBiophysicsCardiovascular systemCaspaseCell Culture TechniquesCell SurvivalCell physiologyCellsCellular Stress ResponseClinical TreatmentCollagenCoupledCutaneousCytochrome c PeroxidaseDataDeuteriumDevelopmentDiabetes MellitusDiabetes preventionDiseaseDisulfidesElectron TransportEnergy MetabolismExpression ProfilingFamilyFamily memberFibroblastsFoundationsFutureHumanHydrogenHypertensionInterventionLipidsLocationMammalian CellMass Spectrum AnalysisMediatingMetabolicMetal Ion BindingMitochondriaMolecularMolecular ConformationMolecular StructureMyocardial IschemiaN-terminalOxidation-ReductionOxidative StressOxidoreductaseOxygenPTB DomainPathway interactionsPeripheralPeroxidasesPlayPost-Translational Protein ProcessingProductionProtein CProtein FamilyProtein IsoformsProtein Tyrosine KinaseProteinsReactive Oxygen SpeciesReperfusion InjuryRoleSeveritiesSignal TransductionSourceStrokeStructureSulfhydryl CompoundsSuperoxidesSystemTherapeuticWound HealingX-Ray Crystallographybasebiophysical techniquescytochrome cdesigndiabetes mellitus therapydisulfide bondendothelial dysfunctionhuman diseasein vivoinhibitor/antagonistinsightmouse ShcA proteinnovelp66(ShcA) proteinprotein functionreceptorresponsesmall moleculetherapeutic targettissue culture
项目摘要
Oxidative stress is a key determinant in the development of diabetes related microvascular and cardiovascular
complications. ShcA (Src homology and collagen homology) family proteins are prototypical signaling
adaptors that regulate a diverse array of cellular response pathways (e.g., tyrosine kinase (TK) signaling). One
ShcA family member, p66Shc, is also a major source (~30%) of reactive oxygen species (ROS) production in
mammalian cells. ShcA-mediated ROS production is a determinant of stroke size in cardiac ischemia
reperfusion injury and endothelial dysfunction in diabetes (e.g., delayed cutaneous wound healing) and
hypertension. The molecular basis for ShcA enzymatic function is poorly defined or unknown. This project is
focused on defining how ShcA proteins function at the molecular level using a range of biophysical methods.
ShcA proteins have proven difficult to study in defined systems due to their low expression profile in standard
lab systems, they are conformationally variable and prone to posttranslational modification, and they interact
with a broad range of proteins in vivo. The overarching hypothesis of this project is that ShcA proteins function
as molecular rheostats to modulate redox state, cyt c activity, and metabolic flux in a location, conformation,
and binding-dependent manner. We will investigate this hypothesis by pursuing the following Specific Aims: 1)
define the enzymatic mechanism of ShcA-mediated ROS production, 2) define the functional interactions
between ShcA proteins and cytochrome c, and 3) determine the structural basis for ShcA-mediated function.
Outflow from this project will provide a molecular basis for ShcA function as a means to facilitate downstream
development of isoform specific inhibitors of ShcA-mediated ROS production. In addition, ShcA proteins
function at the crossroads of cell survival and apoptosis so this project will further define the role that ShcA
proteins play in determining cellular stress response.
氧化应激是糖尿病相关微血管和心血管发展的关键决定因素
并发症ShcA(Src同源性和胶原同源性)家族蛋白是典型的信号传导蛋白,
调节多种细胞应答途径的衔接子(例如,酪氨酸激酶(TK)信号传导)。一
ShcA家族成员p66Shc也是大肠杆菌中活性氧(ROS)产生的主要来源(约30%)。
哺乳动物细胞ShcA介导的ROS产生是心肌缺血时卒中大小的决定因素
糖尿病中的再灌注损伤和内皮功能障碍(例如,皮肤伤口愈合延迟)和
高血压ShcA酶功能的分子基础定义不清或未知。这个项目是
专注于使用一系列生物物理方法在分子水平上定义ShcA蛋白质的功能。
ShcA蛋白已被证明难以在确定的系统中研究,这是由于它们在标准环境中的低表达谱。
在实验室系统中,它们是构象可变的,易于翻译后修饰,并且它们相互作用
与多种蛋白质结合。该项目的首要假设是ShcA蛋白的功能
作为分子变阻器来调节氧化还原状态、细胞色素C活性和代谢通量,
和依赖绑定的方式。我们将通过追求以下具体目标来研究这一假设:1)
确定ShcA介导的ROS产生的酶机制,2)确定功能相互作用
ShcA蛋白和细胞色素c之间的关系,以及3)确定ShcA介导的功能的结构基础。
该项目的流出物将为ShcA功能提供分子基础,作为促进下游
开发ShcA介导的ROS产生的同种型特异性抑制剂。此外,ShcA蛋白
ShcA在细胞生存和细胞凋亡的十字路口发挥作用,因此该项目将进一步定义ShcA的作用
蛋白质在决定细胞应激反应中起作用。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
High-Throughput Protein Production of Membrane Proteins in Saccharomyces cerevisiae.
酿酒酵母膜蛋白的高通量蛋白质生产。
- DOI:10.1007/978-1-4939-9624-7_11
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Johnson,JenniferM;Hays,FranklinA
- 通讯作者:Hays,FranklinA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANKLIN Alan HAYS其他文献
FRANKLIN Alan HAYS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANKLIN Alan HAYS', 18)}}的其他基金
Deciphering ShcA-mediated ROS Production as a Novel Intervention Strategy in Diabetes Therapy
解读 ShcA 介导的 ROS 产生作为糖尿病治疗的新型干预策略
- 批准号:
9349551 - 财政年份:2016
- 资助金额:
$ 28.25万 - 项目类别:
Deciphering ShcA-mediated ROS Production as a Novel Intervention Strategy in Diabetes Therapy
解读 ShcA 介导的 ROS 产生作为糖尿病治疗的新型干预策略
- 批准号:
9193886 - 财政年份:2016
- 资助金额:
$ 28.25万 - 项目类别:
MOLECULAR DETERMINANTS OF GEMCITABINE (Franklin Hays)
吉西他滨的分子决定因素 (Franklin Hays)
- 批准号:
9099947 - 财政年份:
- 资助金额:
$ 28.25万 - 项目类别:
MOLECULAR DETERMINANTS OF GEMCITABINE (Franklin Hays)
吉西他滨的分子决定因素 (Franklin Hays)
- 批准号:
8539821 - 财政年份:
- 资助金额:
$ 28.25万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 28.25万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 28.25万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 28.25万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 28.25万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 28.25万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 28.25万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 28.25万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 28.25万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 28.25万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 28.25万 - 项目类别: